SearchPublisher and Institutes
You are here: Home :: Keyword index :: phy bis ray :: proportional risk allocation - protein assembly 
prostate cancer
Items for "prostate cancer"
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer
In a pilot trial we investigated whether significant differences in prostate cancer (PCA) imaging would be observed using [11C]acetate and [11C]choline positron emission tomography (PET). METHODS: Twelve patients were studied with both radiotracers...
Keywords: Azetat, Cholin, Positronenemissionstomographie, Prostatakarzinom
01/2003 | Nuklearmedizin, SchattauerThe role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition
Several members of the kallikrein-related peptidase family of serine proteases have proteolytic activities that may affect cancer progression; however, the
Keywords: E-cadherin, EMT, KLK4, Migration, prostate cancer, PSA
06/2006 | Biological Chemistry, Walter de GruyterHuman kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
Human kallikrein 4 (hK4) is a member of the expanded family of human kallikreins, a group of 15 secreted proteases...
Keywords: cancer metastasis, extracellular matrix, human kallikrein 4, ovarian cancer, prognostic markers, prostate cancer, serine protease, serine protease inhibitors
06/2006 | Biological Chemistry, Walter de GruyterA sensitive proximity ligation assay for active PSA
Prostate-specific antigen (PSA) is a widely used marker for prostate cancer. The utility of PSA tests is limited by their inability to differentiate prostate cancer from non-malignant conditions such as benign prostatic hyperplasia and prostatitis...
Keywords: immunoassay, peptide, prostate cancer, prostate-specific antigen
06/2006 | Biological Chemistry, Walter de GruytermRNA expression analysis of human kallikrein 11 (KLK11 ) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
Kallikrein 11 (
Keywords: free PSA, kallikreins, PCR, prostate, prostate cancer, prostate-specific antigen, PSA, serine proteases, tumor biomarkers
06/2006 | Biological Chemistry, Walter de GruyterImproved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
Human kallikrein 11 (hK11) was evaluated in a percentage free PSA-based artificial neural network (ANN) to reduce unnecessary prostate biopsies...
Keywords: artificial neural network (ANN), human kallikrein 11, prostate cancer, prostate-specific antigen
06/2006 | Biological Chemistry, Walter de GruyterProtein profiling as a diagnostic tool in clinical chemistry: a review
Serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) appears to be an important diagnostic tool for a whole range of diseases...
Keywords: biomarker, decision tree, diagnostic value, ovarian cancer, post-analytical conditions, pre-analytical conditions, prostate cancer, protein profiling, proteomics, surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
12/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterComparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
The anticarcinogenic and antioxidant properties of vitamins A, C, E and pro- or antioxidant properties of trace metals have recently attracted increased attention...
Keywords: lipid peroxidation, prostate cancer, trace elements, vitamins
02/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterProstataspezifisches Antigen: Bedeutung für die Diagnostik des Prostatakarzinoms bei geriatrischen Patienten / Prostate-specific antigen: significance for the diagnosis of prostate cancer in geriatric patients
Bei Männern der westlichen Welt ist das Prostatakarzinom die häufigste maligne Erkrankung...
Keywords: benigne Prostatahyperplasie, freies PSA, Gesamt-PSA, komplexiertes PSA, Präanalytik, prostataspezifisches Antigen, Prostatakarzinom, benign prostatic hyperplasia, complexed PSA, free PSA, pre-analytical procedures, prostate cancer, prostate-specific antigen, total PSA
02/2007 | LaboratoriumsMedizin, Walter de Gruyter